Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Dollar Tree Q4 2025 Earnings Call - Multi-price rollout is proving the growth engine, but traffic, tariffs and freight keep the margin story guarded
Dollar Tree closed fiscal 2025 with clear momentum: Q4 sales rose 9% to $5.5 billion, comps were +5%, gross margin expanded 150 basis points, and adjusted EPS jumped 21%. Management pinned the strengt...
- Q4 results: net sales $5.5 billion, revenue up 9%, comparable store sales +5% (ticket-driven), traffic down 1.2% for the quarter.
- Multi-price is core to the story: in Q4 multi-price represented ~16% of sales, and management added ~2,400 inline 3.0 multi-price stores during the year, totaling ~5,300 locations.
- Household acceleration: Dollar Tree U.S. households reached a record 102 million, adding 6.5 million net new households in Q4, with growth broad-based across income cohorts.
- +12 more takeaways
VinFast Q4 2025 Earnings Call - Record deliveries and clearer cost roadmap, but big losses and heavy CapEx remain
VinFast closed 2025 with its strongest quarter yet: record quarterly deliveries, revenue doubling year over year, and early signs of unit-cost improvements. Management framed 2026 as a scale year, wit...
- Record deliveries, with full-year EV deliveries of 196,919 and a Q4 record of 86,557 vehicles.
- Two-wheeler business surged, with full-year deliveries of 406,496 units and management targeting at least 2.5x growth in 2026.
- Revenue for Q4 2025 was $1.6 billion, up 118% quarter over quarter and 139% year over year; full-year revenue was $3.6 billion, up 105% year over year.
- +14 more takeaways
CytomX Therapeutics Q4 2025 Earnings Call - Varseta-M shows strong responses and manageable toxicity with dose optimization
CytomX used its earnings call to put a stake in the ground for Varseta-M, a Probody EpCAM-targeting ADC. Updated phase 1 data across 93 patients show notable anti-tumor activity in heavily pretreated ...
- Varseta-M phase 1 program updated, dataset cutoff January 16, 2026, total enrollment 93 patients across escalation, expansion, and dose optimization cohorts.
- Efficacy signal: confirmed overall response rate (ORR) of 32% at 10 mg/kg and 20% at 8.6 mg/kg in the expansion cohorts (n=60 for 7.2–10 mg/kg cohorts).
- Progression-free survival improved since prior disclosure, now ~7.1 months at 10 mg/kg and ~6.8 months at 8.6 mg/kg, up from 5.8 months reported in May 2025.
- +13 more takeaways
Townsquare Media Q4 2025 Earnings Call - Digital engine holds as AI cuts remnant revenue; programmatic and direct sales power 2026 recovery
Townsquare says 2025 closed on plan, but the story is more nuanced. The company has effectively become a digital-first local media operator, with digital now ~55% of revenue and 56% of segment profit....
- Townsquare completed 2025 in line with guidance: Q4 net revenue $106.5 million and full-year net revenue $427.4 million (down 5.2% total year-over-year).
- Digital now drives the company: ~55% of total net revenue in 2025 came from digital, up from 52% in 2024, and 56% of segment profit was from digital (up from 50%).
- AI and search disruption hit remnant inventory hard: unique monthly visitors to O&O sites fell from ~70 million in 2024 to ~40 million in 2025, roughly a 45% decline, reducing remnant revenue (nearly 100% margin) from ~$20 million in 2024 to ~$12 million in 2025.
- +11 more takeaways
Niu Technologies Q4 2025 Earnings Call - Pivoting short-term volume for higher-margin e-motorcycles and China share
Niu reported a quarter of transition, not collapse. Q4 deliveries fell to about 172,000 units, down 24% year-over-year, driven by a planned pause as China moved to new national e-bike standards and a ...
- Q4 deliveries were roughly 172,000 units, a 23.8% year-over-year decline, comprised of ~158,782 units in China (-12% YoY) and ~14,000 units overseas (-68% YoY).
- Full-year 2025 sales reached 1.19 million units, up 29% year-over-year; China deliveries were 1.11 million units, up 46%, while overseas fell to 80,000 units, down 51%.
- Total revenue for 2025 was RMB 4.31 billion, a 31% increase year-over-year; Q4 revenue was RMB 676 million, down 17% YoY.
- +11 more takeaways
Zepp Health Corporation Q4 2025 Earnings Call - Premiumization, AI coaching and product mix drive double-digit growth and record gross margin
Zepp pitched 2025 as the year it stopped being a volume-led wearable maker and started behaving like a premium, AI-enabled hybrid training platform. The company reported strong Q4 momentum with revenu...
- Q4 2025 revenue was $85.2 million, up 43% year-over-year, beating the upper end of guidance.
- Full-year Amazfit branded product revenue rose 51% year-over-year, company says, signaling successful premiumization.
- Company reported a record Q4 gross margin around 40.3% to 40.4%, up roughly 3.6 percentage points year-over-year, driven by mix shift to higher-margin Adventure and premium lines.
- +12 more takeaways
Lennar Q1 2026 Earnings Call - Asset-light, tech-driven cost cuts position margins to stabilize amid weak affordability
Lennar used the quarter to prove that strategy matters when demand is soft. Management doubled down on an asset-light, land-light manufacturing model, pushed cycle times and direct costs lower, and le...
- Lennar reported Q1 2026 gross margin of 15.2%, SG&A of 9.8%, net margin of 5.3%, producing net income of $229 million and EPS of $0.93.
- Q1 average sales price was $374,000, down 8% year-over-year, reflecting continued use of incentives to support affordability.
- Sales incentives on deliveries were 14.1% in Q1, roughly flat with Q4 2025 at 14.5%, while new order incentives showed early signs of being lower than delivery incentives.
- +17 more takeaways
Angel Studios Q4 2025 Earnings Call - Guild Growth Powers Revenue Surge and Path to Profitability
Angel reported a blowout Q4 and full-year 2025 driven by explosive Guild membership growth. Q4 revenue reached $110 million, up 254% year over year, and full-year revenue was roughly $322 million, up ...
- Q4 2025 revenue was $110 million, up 254% year over year; full-year 2025 revenue was about $322 million, up 233% from 2024.
- Angel’s Guild now stands at 2.2 million members, and management calculates a $360 million ARR run rate using a trailing 12-month ARPM of $13.67.
- Guild revenue comprised 62.9% of Q4 revenue, up from 46.3% in Q4 2024, reflecting the strategic emphasis on membership economics.
- +15 more takeaways
Vista Gold FY2025 Earnings Call - Mt Todd feasibility sets the stage for near-term development and sharp gold-price leverage
Vista reported a pivotal 2025, anchored by a July feasibility study for the Mt Todd gold project that reframes development as a 15,000 tons per day operation prioritizing higher grade ore, lower initi...
- Vista completed a new Mt Todd feasibility study in July 2025 that designs a 15,000 tpd plant focused on higher grade ore and lower initial capital intensity.
- Feasibility economics: NPV5 of $1.1 billion at $2,500/oz, $2.2 billion at $3,300/oz, and $4.5 billion at $5,000/oz; IRRs of 27.8%, 44.7% and 74.5% respectively, with paybacks of 2.7, 1.7 and 1.3 years.
- Management projects an all-in sustaining cost of roughly $1,500/oz, and at $3,300/oz expects approximately $300 million of annual free cash flow from Mt Todd.
- +11 more takeaways
reAlpha Q4 2025 Earnings Call - Platform traction: Prevu closed, InstaMortgage pending to add lending and scale
reAlpha closed 2025 with a sharp revenue rebound and a strategic push to stitch brokerage, mortgage, title, and AI into one coordinated homebuying platform. Full-year revenue rose 376% to $4.5 million...
- Full-year 2025 revenue increased 376% to $4.5 million, Q4 revenue rose 70% YoY to $0.9 million.
- Total transaction volume for 2025 was $116.1 million, with gross profit of $2.5 million for the year.
- Cash and cash equivalents ended 2025 at approximately $7.8 million, a 149% YoY increase, and the company paid off its Streeterville note, leaving no parent-level debt.
- +12 more takeaways